CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,222
- in 5 filings, $701K under 10b5-1 plans
Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion | +4,000 | 4,000 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −850 | $10.82 | $9K | 3,150 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −2,173 | $11.80 | $26K | 977 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −850 | $12.41 | $11K | 127 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −127 | $14.06 | $2K | 0 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion | +20,000 | 20,000 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −4,430 | $10.84 | $48K | 15,570 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −10,327 | $11.74 | $121K | 5,243 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −4,693 | $12.41 | $58K | 550 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −550 | $14.03 | $8K | 0 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion | +1,000 | 1,000 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −236 | $10.87 | $3K | 764 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −561 | $11.82 | $7K | 203 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −127 | $12.36 | $2K | 76 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −63 | $13.75 | $867 | 13 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Sale | −13 | $14.85 | $193 | 0 |
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −31,250 | 562,500 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion · Class B Common Stock | −4,000 | 527,000 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion · Class B Common Stock | −20,000 | 468,000 | ||
| 2023-07-12 | Gibson Christopher Chief Executive Officer | Conversion · Class B Common Stock | −1,000 | 121,875 |
Page 36 of 41 · 805 trades